SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Inderjeet Singh, Shyambalaji Achuthan, Amitava Chakrabarti, Sujit Rajagopalan, Anand Srinivasan, Debasish Hota, Influence of pre-operative use of serotonergic antidepressants (SADs) on the risk of bleeding in patients undergoing different surgical interventions: a meta-analysis, Pharmacoepidemiology and Drug Safety, 2015, 24, 2
  2. 2
    Cui Cui, Mari T. Kaartinen, Serotonin (5-HT) inhibits Factor XIII-A-mediated plasma fibronectin matrix assembly and crosslinking in osteoblast cultures via direct competition with transamidation, Bone, 2015, 72, 43

    CrossRef

  3. 3
    C. Moura, S. Bernatsky, M. Abrahamowicz, A. Papaioannou, L. Bessette, J. Adachi, D. Goltzman, J. Prior, N. Kreiger, T. Towheed, W. D. Leslie, S. Kaiser, G. Ioannidis, L. Pickard, L.-A. Fraser, E. Rahme, Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS), Osteoporosis International, 2014, 25, 5, 1473

    CrossRef

  4. 4
    Maurizio Rossini, Ombretta Viapiana, Silvano Adami, Luca Idolazzi, Stefano Buda, Chiara Veronesi, Luca Degli Esposti, Davide Gatti, Medication Use Before and After Hip Fracture: A Population-Based Cohort and Case-Control Study, Drugs & Aging, 2014, 31, 7, 547

    CrossRef

  5. 5
    Olivier Bruyère, Jean-Yves Reginster, Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome, Endocrine, 2014,

    CrossRef

  6. 6
    Jean-Pascal Roussy, Louis Bessette, Sasha Bernatsky, Elham Rahme, Jean Lachaine, Rates of Non-vertebral Osteoporotic Fractures in Rheumatoid Arthritis and Postfracture Osteoporosis Care in a Period of Evolving Clinical Practice Guidelines, Calcified Tissue International, 2014, 95, 1, 8

    CrossRef

  7. 7
    Jonathan Smithson, Philip B. Mitchell, A worldwide yearly survey of new data in adverse drug reactions, 2014,

    CrossRef

  8. 8
    Jennifer Couturier, Alice Sy, Natasha Johnson, Sheri Findlay, Bone Mineral Density in Adolescents With Eating Disorders Exposed to Selective Serotonin Reuptake Inhibitors, Eating Disorders, 2013, 21, 3, 238

    CrossRef

  9. 9
    B. Abrahamsen, K. H. Rubin, P. A. Eiken, R. Eastell, Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study, Osteoporosis International, 2013, 24, 1, 321

    CrossRef

  10. 10
    Christian Lange-Asschenfeldt, Die Knochen bleiben stabil, InFo Neurologie & Psychiatrie, 2013, 15, 7-8, 14

    CrossRef

  11. 11
    Chia-Fen Tsai, Chia-Jen Liu, Tzeng-Ji Chen, Chi-Jen Chu, Han-Chieh Lin, Fa-Yauh Lee, Tung-Ping Su, Ching-Liang Lu, Increased incidence of orthopedic fractures in cirrhotic patients: A nationwide population-based study, Journal of Hepatology, 2013, 58, 4, 706

    CrossRef

  12. 12
    Carlo Galli, Guido Macaluso, Giovanni Passeri, Serotonin: a novel bone mass controller may have implications for alveolar bone, Journal of Negative Results in BioMedicine, 2013, 12, 1, 12

    CrossRef

  13. 13
    Elizabeth M. Haney, Chadi Calarge, M. Michael Bliziotes, Translational Endocrinology of Bone, 2013,

    CrossRef

  14. 14
    Chun-Sick Eom, Sang Min Park, Kyung-Hwan Cho, Use of antidepressants and the risk of breast cancer: a meta-analysis, Breast Cancer Research and Treatment, 2012, 136, 3, 635

    CrossRef